全文获取类型
收费全文 | 2205篇 |
免费 | 246篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 77篇 |
妇产科学 | 43篇 |
基础医学 | 157篇 |
口腔科学 | 93篇 |
临床医学 | 265篇 |
内科学 | 451篇 |
皮肤病学 | 117篇 |
神经病学 | 125篇 |
特种医学 | 161篇 |
外科学 | 416篇 |
综合类 | 125篇 |
现状与发展 | 30篇 |
预防医学 | 146篇 |
眼科学 | 26篇 |
药学 | 101篇 |
中国医学 | 5篇 |
肿瘤学 | 111篇 |
出版年
2024年 | 18篇 |
2023年 | 188篇 |
2022年 | 43篇 |
2021年 | 51篇 |
2020年 | 80篇 |
2019年 | 51篇 |
2018年 | 90篇 |
2017年 | 76篇 |
2016年 | 63篇 |
2015年 | 85篇 |
2014年 | 138篇 |
2013年 | 108篇 |
2012年 | 94篇 |
2011年 | 93篇 |
2010年 | 117篇 |
2009年 | 115篇 |
2008年 | 69篇 |
2007年 | 90篇 |
2006年 | 57篇 |
2005年 | 54篇 |
2004年 | 45篇 |
2003年 | 41篇 |
2002年 | 42篇 |
2001年 | 26篇 |
2000年 | 27篇 |
1999年 | 44篇 |
1998年 | 42篇 |
1997年 | 53篇 |
1996年 | 46篇 |
1995年 | 42篇 |
1994年 | 34篇 |
1993年 | 37篇 |
1992年 | 15篇 |
1991年 | 21篇 |
1990年 | 14篇 |
1989年 | 37篇 |
1988年 | 26篇 |
1987年 | 33篇 |
1986年 | 12篇 |
1985年 | 25篇 |
1984年 | 12篇 |
1983年 | 5篇 |
1982年 | 12篇 |
1981年 | 16篇 |
1980年 | 15篇 |
1978年 | 9篇 |
1976年 | 13篇 |
1975年 | 12篇 |
1974年 | 5篇 |
1966年 | 4篇 |
排序方式: 共有2473条查询结果,搜索用时 15 毫秒
91.
Bishara S. Atiyeh Hussein A. Hashim Michel T. Rubeiz Ashraf M. Hamdan Fadi F. Bitar Haytham M. Serhal 《Journal of plastic surgery and hand surgery》2013,47(3):343-346
Noma neonatorum should be differentiated from noma, in that it is typically a disease of seriously ill premature infants whose birth weight was low, and is caused by Pseudomonas aerugenosa septicaemia. We know of only two case reports of noma neonatorum involving newborn infants born at full term, so we report here another case of noma neonatorum in a neonate born at full term. In addition we describe the differences between noma neonatorum and noma (cancrum oris), a clinically related entity. 相似文献
92.
Rehab A. Karam Noha A. Rezk Hadeel M. Abdelrahman Tamer H. Hassan Doaa Mohammad Haitham M. Hashim Nelly R.A. Abdel Fattah 《Research in developmental disabilities》2013,34(7):2092-2097
Catechol-O-methyltransferase (COMT) plays an important role in the catabolism of brain dopamine and norepinephrine, which have been implicated in the pathogenesis of Autism spectrum disorder (ASD) as well as in other neuropsychatric disorders. We aimed to investigate the association of COMT Val158Met gene polymorphism with ASD and to examine the influence of such genotypes on hyperactivity symptoms in ASD patients. Eighty ASD patients (mean age 9 ± 1.9 years) and 100 control children (mean age 8.9 ± 1.9 years) were examined. COMT Val58Met polymorphism was genotyped using Tetra-primer ARMS-PCR method. The clinical diagnosis of ASD and ADHD were confirmed according to the DSM-IV criteria for research. We found no significant difference in genotypes or alleles’ frequencies of COMT Val158Met polymorphism between ASD patients and control group. There was a significant association between COMT (Val/Val) genotype and both increasing CARS (p = 0.001) and hyperactivity scores (p = 0.006). Regarding Conner's Score, the DSM-IV hyperactive impulsive were significantly higher in Val/Val genotype than both Met/Val and Met/Met genotypes (p = 0.03). Our data suggested an association between COMT Val58Met polymorphism and hyperactivity symptoms in Egyptian children with ASD. 相似文献
93.
94.
95.
Classifying CT/MR findings in patients with suspicion of hepatocellular carcinoma: Comparison of liver imaging reporting and data system and criteria‐free Likert scale reporting models
下载免费PDF全文
![点击此处可从《Journal of magnetic resonance imaging : JMRI》网站下载免费的PDF全文](/ch/ext_images/free.gif)
96.
97.
A. Touré D. Cissé KJJO. Kadio A. Camara FA. Traoré A. Delamou S. Sididé C. Kouyaté IS. Bangoura MM. Diallo TM. Tounkara F. Traoré MS. Sow N. Khanafer M. Cissé 《Revue d'épidémiologie et de santé publique》2018,66(4):273-279
Background
Late or inadequate therapeutic management increases the risk of mortality associated with HIV/AIDS. The aim of this study was to analyze the proportion and factors associated with loss of follow-up in HIV patients who receiving antiretroviral therapy at Conakry.Methods
A retrospective cohort study was conducted in HIV patients aged over 15 years and who receiving antiretroviral therapy. Between August 1, 2008 and July 31, 2015, all patients managed by the ambulatory treatment center of the Guinean Women Association against AIDS and sexually and transmissible infection were included. Loss of follow-up was defined as no follow-up visit within 3 months. Kaplan–Meier curves and multivariate Cox regression modelResults
614 patients aged 36.3 ± 11.2 years, mainly females (68.4%) and living in Conakry (80.5%) were included. Among them, 104 were loss to follow-up, corresponding to a proportion rate of 16.9% (95% CI: 14.2–19.7%) or 5.79/100 person-years. The results of multivariate analyses showed that factors independently associated with loss of follow-up were malnutrition (AHR = 7.05; 95% CI: 2.05–24.27; P = 0.002) and CD4 cells account at the initiation of AHR (2.35; 95% CI: 1.61–6.39; P = 0.016) in patients with 201–350 CD4/μL and 5.83 (95% CI: 2.85–11.90; P < 0.001) in patients with less than 150 CD4/μL.Conclusion
Despite efforts of health care workers and free antiretroviral therapy, many patients were loss to follow-up. Multivariate analysis showed that malnutrition and low CD4 account were independently associated with loss to follow-up. 相似文献98.
Mahmoud Hashim Boris M. Pfeiffer Robert Bartsch Maarten Postma Bart Heeg 《Value in health》2018,21(1):9-17
Background
In previous studies, correlation between overall survival (OS) and surrogate endpoints like objective response rate (ORR) or progression-free survival (PFS) in advanced non-small cell lung cancer (NSCLC) was poor. This can be biased by crossover and postprogression treatments.Objectives
To evaluate the relationship between these two surrogate endpoints and OS in advanced NSCLC studies that did not allow for crossover or reported balanced post-progression treatments.Methods
A systematic review in patients with advanced NSCLC receiving second- and further-line therapy was performed. The relationship between the absolute difference in ORR or median PFS (mPFS) and the absolute difference in median OS (mOS) was assessed using the correlation coefficient (R) and weighted regression models. The analysis was repeated in predefined data cuts based on crossover and balance of postprogression treatments. When the upper limit of R’s 95% confidence interval (CI) was more than 0.7, the surrogate threshold effect (STE) was estimated.Results
In total, 146 randomized clinical trials (43,061 patients) were included. The mean ORR, mPFS, and mOS were 12.2% ± 11.2%, 3.2 ± 1.3 months, and 9.6 ± 4.1 months, respectively. The correlation coefficients of ORR and mPFS were 0.181 (95% CI 0.016–0.337) and 0.254 (95% CI 0.074–0.418), respectively, with mOS. Nevertheless, in trials that did not allow crossover and reported balanced postprogression treatments, the correlation coefficients of ORR and mPFS were 0.528 (95% CI 0.081–0.798) and 0.778 (95% CI 0.475–0.916), respectively, with mOS. On the basis of STE estimation, in trials showing significant treatment effect size of 41.0% or more ORR or 4.15 or more mPFS months, OS benefit can be expected with sufficient certainty.Conclusions
Crossover and postprogression treatments may bias the relationship between surrogate endpoints and OS. Presented STE calculation can be used to interpret treatment effect on either ORR or PFS when used as primary endpoints. 相似文献99.